Myriad Genetics, Inc.
Myriad Genetics, Inc. (MYD.DE) Stock Competitors & Peer Comparison
See (MYD.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MYD.DE | €26.72 | +0.00% | 2.2B | -256.92 | -€0.10 | N/A |
| PHIA.DE | €48.00 | +0.00% | 43.4B | 13.73 | €3.50 | +3.67% |
| BTL.DE | €58.80 | +0.00% | 29.6B | 30.31 | €1.94 | N/A |
| SRT3.DE | €209.30 | -4.34% | 14.7B | 90.98 | €2.34 | +0.35% |
| SRT.DE | €168.40 | -3.77% | 11.8B | 72.43 | €2.35 | +0.35% |
| FIE.DE | €43.15 | -3.14% | 3.7B | 20.35 | €2.17 | +2.60% |
| AFX.DE | €25.22 | -4.61% | 2.3B | 15.99 | €1.61 | +2.14% |
| 1SXP.F | €14.64 | -1.48% | 2.3B | 15.09 | €0.99 | +1.20% |
| DY2.F | €9.82 | -4.03% | 2B | -3.90 | -€2.57 | +5.43% |
| 2B4.F | €19.64 | -8.99% | 1.4B | 82.40 | €0.25 | N/A |
Stock Comparison
MYD.DE vs PHIA.DE Comparison April 2026
MYD.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYD.DE stands at 2.2B. In comparison, PHIA.DE has a market cap of 43.4B. Regarding current trading prices, MYD.DE is priced at €26.72, while PHIA.DE trades at €48.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYD.DE currently has a P/E ratio of -256.92, whereas PHIA.DE's P/E ratio is 13.73. In terms of profitability, MYD.DE's ROE is -0.16%, compared to PHIA.DE's ROE of +0.08%. Regarding short-term risk, MYD.DE and PHIA.DE have similar daily volatility (0.00).Check PHIA.DE's competition here